COVID and Trading

The markets seem to be willing to look past the bout of Covid raging through China at the moment. As a result, traders see an opportunity to buy stocks.

Sentiment was given another boost ahead of today’s US CPI report with China continuing to scale back restrictions and suggesting international travel could be on the horizon.

If China continues to re-open its economy, slowly but surely, then the China A50 may continue to move higher as the economy begins to expand once again.

Poor economic data combined with the constant closing and re-opening of certain areas in China have the China A50 on its heels.

Moderna shares have been under pressure this year as interest around Covid-19 vaccines wanes.

The German ZEW and the continued on again/off again lockdowns in China are contributing to fears of a global slowdown or recession.

China is back and looking to move forward. With some help from the government, the trough in the PMI data may be behind us.

The lockdowns in China have led to weaker manufacturing and services data. Is this just the beginning or is there more to come?

IAG faces a major challenge as it strives to return to profit in 2022 as a myriad of headwinds plague the airline industry.

Until confidence returns that prices from China will move higher, Gold may begin trading in a range.

AstraZeneca’s results will benefit from the acquisition of Alexion, but questions remain over its Covid-19 drugs and the outlook in China.